COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains

Acta Derm Venereol. 2022 Jun 9:102:adv00728. doi: 10.2340/actadv.v102.888.
No abstract available

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Chilblains* / diagnosis
  • Chilblains* / etiology
  • Humans
  • SARS-CoV-2
  • Vaccination / adverse effects

Substances

  • COVID-19 Vaccines